Skip to main content
Premium Trial:

Request an Annual Quote

Packard BioScience Reports Jump in Q2 Revenues

NEW YORK, Aug 3 – Packard BioScience said its second-quarter revenues rose 27 percent to $49 million, compared with $38.6 million in the year-ago quarter, as revenues from liquid handling and automated sample preparation technologies rose.

During the quarter, service revenues, which had dropped over the past year, also increased 10 percent compared with the same period one year ago.

"Our revenues and operating profit both exceeded expectations this quarter," Emery Olcott, Packard’s CEO, said in a statement. "Some of the initiatives we took in the second quarter, especially in the area of microarray scanners, are beginning to pay dividends, and our liquid handling and automated sample preparation products continue to grow in excess of 30 percent."

Last month Packard of Meriden, Conn., entered into a deal to be acquired by PerkinElmer. The merger is expected to close in the fourth quarter.

During the quarter, Packard’s research and development expenses fell slightly to $6.9 million, compared with $7.0 million in the year ago period.

Packard posted net earnings to $1.3 million, or two cents a share from continuing and discontinued operations, compared with $2.0 million, or three cents a share from continuing and discontinued operations. A consensus estimate of five analysts polled by First Call/Thomson Financial predicted three cents.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.